Organogenesis Holdings Inc (ORGO) Hedge Fund & Institutional Holdings (Q2 2026)

ORGO ranks #3915 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

ORGO is a disclosed holding of Cliff Asness (AQR Capital Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

136 institutions disclose a position in ORGO, but none treat it as a major bet — even Soleus Capital Management, L.P., its most concentrated holder, allocates just 0.8% of its own portfolio to it.

True Wealth Design, LLC has trimmed its ORGO position for two straight quarters, cutting it by $1.3K while still holding $199.0.

ORGO is down 5.8% today, but institutions show net buying of $22.5M this quarter — a divergence between today's price move and the underlying institutional flow.

ORGO reported a net loss of $84.2M over the trailing twelve months.

• Not yet profitable — net loss of $84.2M over the trailing twelve months
• Revenue grew 6.5% year over year
• Net income declined year over year, from -$8.2M to -$84.2M
• Operating cash flow was negative, using $10.3M in cash
• Current ratio of 3.62x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.55x equity — within a conventional range